Folgen
Keine Story von Novo Nordisk mehr verpassen.

Novo Nordisk

Filtern
  • 28.04.2011 – 09:40

    Novo Nordisk Increased Operating Profit by 24% in the First Quarter of 2011 (28 April 2011)

    Bagsvaerd, Denmark (ots/PRNewswire) - Sales increased by 15% in Danish kroner and by 11% in local currencies. - Sales of modern insulins increased by 14% (11% in local currencies). - Victoza(R) sales of DKK 1,098 million (growth of 191% in local currencies). - Sales of NovoSeven(R) increased by 6% (4% in local currencies). - Sales in North America increased by 16% (14% ...

  • 01.03.2004 – 13:10

    Switzerland is first to launch new diabetes therapy - Levemir® (insulin detemir)

    Geneva (ots) - Novo Nordisk Switzerland announced today that Levemir® (insulin detemir), a novel, predictable basal insulin analogue with a unique mechanism of prolonging action (scientifically known as protraction), is available for people with type 1 and type 2 diabetes in Switzerland today. The Swiss launch is just the beginning of an exciting global roll-out of ...